Evidence map›Paper›PMID 39652711›Full record

ArticleDiabetes2025

Gain of Function NOTCH3 Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways.

Abhimanyu Garg, Chao Xing, Anil K Agarwal, Aundrea K Westfall, Diana R Tomchick, Xunzhi Zhang, Michelle Xing, Rebecca J Brown

Erratum issuedAbstract read
In one paragraph

Article in Diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Abhimanyu GargSection of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-7209-6986
Chao XingMcDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX.
Anil K AgarwalSection of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX.
Aundrea K WestfallMcDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX.
Diana R TomchickDepartments of Biophysics and Biochemistry, UT Southwestern Medical Center, Dallas, TX.
Xunzhi ZhangMcDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX.
Michelle XingMcDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX.
Rebecca J BrownNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Funding

UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeff G McDonald · 2022 to 2026
$7.4M
Genetic and Metabolic Basis of Familial LipodystrophiesR01DK105448 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Abhimanyu Garg · 2015 to 2026
$6.5M
NIDDK NIH HHS P30 DK127984NIDDK NIH HHS R01 DK105448NIH HHS R01-DK105448Structural Biology LaboratoryTexas Advanced Computing CenterThe University of Texas at AustinUT Southwestern Medical Center
6 · The paper itself

Abstract

Despite elucidation of the molecular genetic basis of several lipodystrophy syndromes, molecular defects in some ultra-rare subtypes of familial lipodystrophies remain unidentified. We analyzed whole-exome sequencing (WES) data of four affected and two unaffected females from an undiagnosed autosomal dominant familial partial lipodystrophy (FPL) pedigree and identified only one novel heterozygous variant, p.Ala1603Tyr, in NOTCH3 meeting the filtering criteria. Further analysis of WES data of 222 patients with unexplained FPL identified two unrelated patients with FPL with novel heterozygous (p.Cys1600Tyr and p.Gln1552Pro) NOTCH3 variants. All variants were clustered in the heterodimerization domain of the negative regulatory region of NOTCH3. RNA sequencing and proteomics analysis of skin fibroblasts revealed significantly higher RNA and protein expression of NOTCH3 and activation of widespread senescence pathways in the patients with FPL versus control study participants. NOTCH3 is highly expressed in adipose tissue and plays many crucial roles in developmental patterning, cell fate decisions, regulation of cell survival, and proliferation. We conclude that gain-of-function missense variants in the negative regulatory region of NOTCH3 cause a novel subtype of FPL by activation of senescence pathways. This novel variety of FPL should be considered for patients without obesity but with early- or childhood-onset diabetes. ARTICLE HIGHLIGHTS: Molecular genetic defects in some ultra-rare subtypes of familial partial lipodystrophies (FPLs) remain unidentified. We investigated whether novel gene variants explain FPL in some undiagnosed patients. We found novel heterozygous gain-of-function missense variants clustered in the heterodimerization domain of the negative regulatory region of NOTCH3 in three unrelated families with FPL. Our study suggests that gain-of-function missense variants in the heterodimerization domain of NOTCH3 cause a novel subtype of FPL by activation of senescence pathways.

Indexed as

Cellular SenescenceGain of Function MutationLipodystrophy, Familial PartialReceptor, Notch3AdultExome SequencingFemaleHumansMaleMiddle AgedMutation, MissensePedigreeNOTCH3 protein, humanReceptor, Notch3

Identifiers

PMID39652711
PMCPMC11842598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.